481 related articles for article (PubMed ID: 28062185)
81. The effect of D-methionine on cochlear oxidative state with and without cisplatin administration: mechanisms of otoprotection.
Campbell KC; Meech RP; Rybak LP; Hughes LF
J Am Acad Audiol; 2003 Apr; 14(3):144-56. PubMed ID: 12859139
[TBL] [Abstract][Full Text] [Related]
82. Allicin ameliorates doxorubicin-induced cardiotoxicity in rats via suppression of oxidative stress, inflammation and apoptosis.
Abdel-Daim MM; Kilany OE; Khalifa HA; Ahmed AAM
Cancer Chemother Pharmacol; 2017 Oct; 80(4):745-753. PubMed ID: 28785995
[TBL] [Abstract][Full Text] [Related]
83. HSV amplicon-mediated neurotrophin-3 expression protects murine spiral ganglion neurons from cisplatin-induced damage.
Chen X; Frisina RD; Bowers WJ; Frisina DR; Federoff HJ
Mol Ther; 2001 Jun; 3(6):958-63. PubMed ID: 11407910
[TBL] [Abstract][Full Text] [Related]
84. Curcumin attenuates peroxynitrite-induced neurotoxicity in spiral ganglion neurons.
Liu W; Fan Z; Han Y; Lu S; Zhang D; Bai X; Xu W; Li J; Wang H
Neurotoxicology; 2011 Jan; 32(1):150-7. PubMed ID: 20869986
[TBL] [Abstract][Full Text] [Related]
85. The injured cochlea as a target for inflammatory processes, initiation of cell death pathways and application of related otoprotectives strategies.
Abi-Hachem RN; Zine A; Van De Water TR
Recent Pat CNS Drug Discov; 2010 Jun; 5(2):147-63. PubMed ID: 20167005
[TBL] [Abstract][Full Text] [Related]
86. Alpha-lipoic acid protects against cisplatin-induced ototoxicity via the regulation of MAPKs and proinflammatory cytokines.
Kim J; Cho HJ; Sagong B; Kim SJ; Lee JT; So HS; Lee IK; Kim UK; Lee KY; Choo YS
Biochem Biophys Res Commun; 2014 Jun; 449(2):183-9. PubMed ID: 24796665
[TBL] [Abstract][Full Text] [Related]
87. Puerarin alleviates the ototoxicity of gentamicin by inhibiting the mitochondria‑dependent apoptosis pathway.
Niu P; Sun Y; Wang S; Li G; Tang X; Sun J; Pan C; Sun J
Mol Med Rep; 2021 Dec; 24(6):. PubMed ID: 34651662
[TBL] [Abstract][Full Text] [Related]
88. The role of Efr3a in age-related hearing loss.
Hu H; Ma Y; Ye B; Wang Q; Yang T; Lv J; Shi J; Wu H; Xiang M
Neuroscience; 2017 Jan; 341():1-8. PubMed ID: 27867060
[TBL] [Abstract][Full Text] [Related]
89. M40403, a superoxide dismutase mimetic, protects cochlear hair cells from gentamicin, but not cisplatin toxicity.
McFadden SL; Ding D; Salvemini D; Salvi RJ
Toxicol Appl Pharmacol; 2003 Jan; 186(1):46-54. PubMed ID: 12583992
[TBL] [Abstract][Full Text] [Related]
90. Friend or foe? Effect of oral resveratrol on cisplatin ototoxicity.
Olgun Y; Kırkım G; Kolatan E; Kıray M; Bagrıyanık A; Olgun A; Kızmazoglu DC; Ellıdokuz H; Serbetcıoglu B; Altun Z; Aktas S; Yılmaz O; Günerı EA
Laryngoscope; 2014 Mar; 124(3):760-6. PubMed ID: 23900991
[TBL] [Abstract][Full Text] [Related]
91. Neuroprotective effect of allicin in a rat model of acute spinal cord injury.
Lv R; Mao N; Wu J; Lu C; Ding M; Gu X; Wu Y; Shi Z
Life Sci; 2015 Dec; 143():114-23. PubMed ID: 26546416
[TBL] [Abstract][Full Text] [Related]
92. Ultrastructural changes in the albino guinea pig cochlea at different survival times following cessation of 8-day cisplatin administration.
Cardinaal RM; De Groot JC; Huizing EH; Smoorenburg GF; Veldman JE
Acta Otolaryngol; 2004 Mar; 124(2):144-54. PubMed ID: 15072416
[TBL] [Abstract][Full Text] [Related]
93. Mitochondria-targeted antioxidant MitoQ reduces gentamicin-induced ototoxicity.
Ojano-Dirain CP; Antonelli PJ; Le Prell CG
Otol Neurotol; 2014 Mar; 35(3):533-9. PubMed ID: 24518411
[TBL] [Abstract][Full Text] [Related]
94. [Ototoxicity of kanamycin sulfate in adult rats and its underlying mechanisms].
Zhang ZC; Yu HM; Liu Q; Tian J; Wang TF; Lai CJ; Zhou XY
Sheng Li Xue Bao; 2011 Apr; 63(2):171-6. PubMed ID: 21505733
[TBL] [Abstract][Full Text] [Related]
95. Allicin prevents oxidized low-density lipoprotein-induced endothelial cell injury by inhibiting apoptosis and oxidative stress pathway.
Chen X; Pang S; Lin J; Xia J; Wang Y
BMC Complement Altern Med; 2016 May; 16():133. PubMed ID: 27207282
[TBL] [Abstract][Full Text] [Related]
96. Ebselen attenuates cisplatin-induced ROS generation through Nrf2 activation in auditory cells.
Kim SJ; Park C; Han AL; Youn MJ; Lee JH; Kim Y; Kim ES; Kim HJ; Kim JK; Lee HK; Chung SY; So H; Park R
Hear Res; 2009 May; 251(1-2):70-82. PubMed ID: 19286452
[TBL] [Abstract][Full Text] [Related]
97. Protective Effect of Avenanthramide-C on Auditory Hair Cells against Oxidative Stress, Inflammatory Cytokines, and DNA Damage in Cisplatin-Induced Ototoxicity.
Umugire A; Nam YS; Nam YE; Choi YM; Choi SM; Lee S; Cho JH; Cho HH
Int J Mol Sci; 2023 Feb; 24(3):. PubMed ID: 36769271
[TBL] [Abstract][Full Text] [Related]
98. Role of p38 MAPK activation and mitochondrial cytochrome-c release in allicin-induced apoptosis in SK-N-SH cells.
Zhuang J; Li Y; Chi Y
Anticancer Drugs; 2016 Apr; 27(4):312-7. PubMed ID: 26771864
[TBL] [Abstract][Full Text] [Related]
99. Down-regulation of AMPK signaling pathway rescues hearing loss in TFB1 transgenic mice and delays age-related hearing loss.
Zhao J; Li G; Zhao X; Lin X; Gao Y; Raimundo N; Li GL; Shang W; Wu H; Song L
Aging (Albany NY); 2020 Apr; 12(7):5590-5611. PubMed ID: 32240104
[TBL] [Abstract][Full Text] [Related]
100. Systemic dexamethasone for the prevention of cisplatin-induced ototoxicity.
Waissbluth S; Salehi P; He X; Daniel SJ
Eur Arch Otorhinolaryngol; 2013 May; 270(5):1597-605. PubMed ID: 22907029
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
